0x

guest@0xbase ~$ read-only mode. Posting requires EU location.

Spotlight Jul 24

Featured Spotlight

Analysis of HIQA's Draft HTA on COVID-19 Vaccination for 2027/2028: Stakeholder Reactions and Policy Outlook

  1. HIQA publishes draft health technology assessment of COVID-19 vaccination in Ireland (hiqa.ie) | 28d ago
  2. IPHA-HSE Framework Agreement on Medicine Pricing 2026-2029 (ipha.ie) | 146d ago
  3. NCPE Assessment: Belzutifan not cost-effective for VHL disease-associated tumours at current price (ncpe.ie) | 87d ago
  4. NIAC Issues Updated Standing COVID-19 Vaccination Recommendations for Ireland (May 2025) (hiqa.ie) | 65d ago
  5. NCPE Recommends Belzutifan (Welireg) Not Reimbursed for VHL Disease on Cost-Effectiveness Grounds (ncpe.ie) | 87d ago
  6. HIQA publishes health technology assessment on RSV immunisation in Ireland (hiqa.ie) | 90d ago
  7. NCPE Recommends Against Reimbursement of Belzutifan (Welireg) for von Hippel-Lindau Disease in Ireland (ncpe.ie) | 63d ago
  8. HIQA publishes 50 inspection reports on residential centres for older people in Ireland (hiqa.ie) | 7d ago
  9. HIQA Publishes Health Technology Assessment of RSV Immunisation in Ireland (hiqa.ie) | 90d ago
  10. FDA approves Guardant Health Shield blood test for colorectal cancer screening in average-risk adults aged 45 and older (accessdata.fda.gov) | 731d ago
  11. FDA approves Shield blood test for colorectal cancer screening in average-risk adults aged 45 and older (accessdata.fda.gov) | 920d ago
  12. HIQA Rapid Health Technology Assessment of RSV Immunisation for Infants and Older Adults in Ireland (hiqa.ie) | 713d ago
  13. HIQA Health Technology Assessment Recommends Shingles Vaccination for Older Adults in Ireland (hiqa.ie) | 738d ago
  14. HIQA publishes 20 inspection reports on designated disability centres (hiqa.ie) | 26d ago
  15. NIAC Updates RSV Vaccination Recommendations for Older Adults in Ireland (hiqa.ie) | 298d ago
  16. Analysis of Neoplasm Adverse Events Associated with GLP-1 Receptor Agonists from FAERS Database (frontiersin.org) | 63d ago
  17. GLP-1 Medications May Reduce Cancer Progression, Study Says (huffpost.com) | 64d ago
  18. Ireland to expand eligibility for state-funded IVF and assisted reproduction treatments from June 2025 (gov.ie) | 63d ago
  19. HIQA 2025 Annual Report details regulatory expansion, patient safety inspections, and health technology assessments in Ireland (hiqa.ie) | 208d ago
  20. HIQA publishes quarterly bulletin summarizing HTA and evidence synthesis work for April–June 2026 (hiqa.ie) | 27d ago
  21. Smart drug GRWD5769 shrinks lung cancer tumours by nearly 30% in patient trial (theguardian.com) | 56d ago
  22. Understanding Patient Safety Culture in Irish Healthcare – HIQA Patient Safety Conference 2024 (youtube.com) | 650d ago
  23. HIQA Publishes 22 Inspection Reports on Irish Disability Residential Centres (hiqa.ie) | 40d ago
  24. Reimbursement dispute over prostate cancer drug delays patient access (medicalindependent.ie) | 62d ago
  25. Electronic record keeping legislation enables digital prescription retention in Irish community pharmacies from June 2026 (ipu.ie) | 87d ago
  26. NIAC Spring 2025 COVID-19 Vaccine Recommendations (hiqa.ie) | 543d ago
  27. Dostarlimab (Jemperli) – NCPE Rapid Review Recommends Full HTA for Endometrial Cancer (ncpe.ie) | 67d ago
  28. HIQA finds insufficient evidence that shingles vaccine prevents dementia (imt.ie) | 65d ago
  29. Rapid Review of Rozanolixizumab (Rystiggo) for gMG Completed by NCPE (ncpe.ie) | 59d ago
  30. GLP-1 Receptor Agonists Associated with Reduced Metastatic Progression in Obesity-Related Cancers (ascopost.com) | 63d ago
  31. Oireachtas Briefing Paper on the Health (Assisted Human Reproduction) Amendment Bill (data.oireachtas.ie) | 102d ago
  32. Seanad Éireann Debate on NCPE Cost-Benefit Analysis (oireachtas.ie) | 172d ago
  33. Government Commits to Six-Month Deadline for Drug Reimbursement Decisions in Ireland (imt.ie) | 62d ago
  34. HIQA Inspection Report Finds Origins Foster Care Compliant with All Standards Assessed (hiqa.ie) | 38d ago
  35. Kerry mental health unit found 'high risk' in medication management and physical restraint practices (independent.ie) | 61d ago
  36. Phase 1 trial of ERAP1 inhibitor GRWD5769 shows tumor shrinkage in six cancer types when combined with cemiplimab (theguardian.com) | 52d ago
  37. Glucagon-like peptide 1 receptor agonists and cancer risk – systematic review (pmc.ncbi.nlm.nih.gov) | 63d ago
  38. Cost-Effectiveness Evidence on Approved Cancer Drugs in Ireland (pmc.ncbi.nlm.nih.gov) | 65d ago
  39. Minister for Health establishes Assisted Human Reproduction Regulatory Authority (gov.ie) | 64d ago
  40. HIQA: Evidence Insufficient to Recommend Shingles Vaccine for Dementia Prevention (independent.ie) | 65d ago
  41. HIQA: Single shingles vaccine's effect on dementia risk cannot be determined (irishtimes.com) | 65d ago
  42. HIQA Recommends Expanding BowelScreen to Ages 50-54; RSV Immunisation Cost-Effective Only with Lower Prices (hiqa.ie) | 87d ago
  43. New Irish legislation enables electronic record keeping in community pharmacies from June 2026 (ipu.ie) | 83d ago
  44. Not enough evidence to confirm shingles vaccination reduces dementia risk, says HIQA (irishexaminer.com) | 65d ago
  45. FDA Guidance on Post-Approval Studies for PMA Medical Devices (2022 Update) (fda.gov) | 1389d ago
  46. Oireachtas Debate on Medicinal Products Questions HSE Reimbursement (oireachtas.ie) | 146d ago
  47. HIQA publishes 50 inspection reports on residential centres for older people (hiqa.ie) | 59d ago
  48. HIQA Publishes Second HTA and Evidence Synthesis Bulletin for 2026 (hiqa.ie) | 25d ago
  49. HSE and NCPE Urged to Approve Reimbursement of Rare Disease Drug for Irish Patients (rte.ie) | 64d ago
  50. HIQA publishes inspections of Tusla children's residential centres in Ireland (hiqa.ie) | 81d ago
Showing page 1 of 2 (95 total results)
← Prev Next →